Article Details

Flare Therapeutics Launches with $82 Million Series A Financing to Advance Precision Oncology ...

Retrieved on: 2021-05-13 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

Flare Therapeutics Launches with $82 Million Series A Financing to Advance Precision Oncology .... View article details on hiswai:

Excerpt

Founded by global scientific leaders in the biology and structure of transcription factors. Financing led by Third Rock Ventures with significant support ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up